Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ala Daka

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Advanced Drug Delivery Reviews|September 15, 2012
RNAi-based nanomedicines for targeted personalized therapyAla Daka, Dan Peer
Inflammatory Bowel Diseases|February 4, 2016
Colitis ImmunoPET: Defining Target Cell Populations and Optimizing PharmacokineticsJason L J Dearling, Ala Daka, Nuphar Veiga, et al.
Immunology Letters|November 3, 2010
A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophagesMeir Goldsmith, Ala Daka, Nadia F Lamour, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Advanced Drug Delivery Reviews|September 15, 2012
RNAi-based nanomedicines for targeted personalized therapyAla Daka, Dan Peer
Inflammatory Bowel Diseases|February 4, 2016
Colitis ImmunoPET: Defining Target Cell Populations and Optimizing PharmacokineticsJason L J Dearling, Ala Daka, Nuphar Veiga, et al.
Immunology Letters|November 3, 2010
A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophagesMeir Goldsmith, Ala Daka, Nadia F Lamour, et al.
Pageof 1